Showing results (231-240 of 1,065) with videos related to
Sort By:
Pageof 107
Current Opinion in Pharmacology|February 28, 2018
The therapeutic potential of metabotropic glutamate receptor modulation for schizophreniaBranden J Stansley, P Jeffrey ConnCurrent Drug Targets. CNS and Neurological Disorders|May 29, 2003
Direct and indirect modulation of the N-methyl D-aspartate receptorM J Marino, P Jeffrey ConnNeuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 25, 2008
Opportunities and challenges of psychiatric drug discovery: roles for scientists in academic, industry, and government settingsP Jeffrey Conn, Bryan L RothAnnual Review of Pharmacology and Toxicology|January 9, 2010
Metabotropic glutamate receptors: physiology, pharmacology, and diseaseColleen M Niswender, P Jeffrey ConnThe International Journal of Neuropsychopharmacology|December 10, 2015
Neurobiological Insights from mGlu Receptor Allosteric ModulationDaniel E O'Brien, P Jeffrey ConnWater Science and Technology : a Journal of the International Association on Water Pollution Research|April 11, 2008
Cross sectoral and scale-up impacts of greywater recycling technologies on catchment hydrological flowsN Bertrand, B Jefferson, P JeffreyACS Chemical Neuroscience|October 23, 2018
Pick Your Model Wisely: Understanding the Negative Symptoms of Schizophrenia in Rodent ModelsSamantha E Yohn, P Jeffrey ConnPharmacological Reviews|June 16, 2022
Allosteric Modulators of Metabotropic Glutamate Receptors as Novel Therapeutics for Neuropsychiatric DiseaseDeborah J Luessen, P Jeffrey ConnNeuropharmacology|September 13, 2017
Positive allosteric modulation of M1 and M4 muscarinic receptors as potential therapeutic treatments for schizophreniaSamantha E Yohn, P Jeffrey ConnJournal of Gastroenterology and Hepatology|August 10, 1999
Coincident increase in periportal expression of iron proteins in the iron-loaded rat liverK A Basclain, G P JeffreyPageof 107